PharmaTutor (February- 2014)
ISSN: 2347 - 7881
Received On: 09/01/2014; Accepted On: 21/01/2014; Published On: 10/02/2014
Author: Vijay Sarkar*, Kailash Chand Yadav
Department of Pharmaceutics,
Regional College of Pharmacy, Sitapura, Jaipur,
Rajasthan-302022, India
vijaysarkarcipla@gmail.com
ABSTRACT: The objective of the present study was to formulate and evaluate controlled and prolonged release transdermal drug delivery system of atenolol for effective management of hypertension. The administration of atenolol via transdermal patch facilitates a direct entry of drug molecules into the systemic circulation, avoiding the first-pass metabolism and drug degradation in the harsh gastrointestinal environment, which are often associated with oral administration. To fulfill above objective transdermal patches of atenolol were prepared by solvent evaporation method using combinations of Eudragit RL100, Ethyl cellulose and PVP in different proportions. Various physicomechanical parameters like weight variation, thickness, folding endurance, drug content, water vapour transmission and tensile strength were evaluated. In-vitro Diffusion Study, skin irritation test and stability studies were also performed. In PVA and Eudragit RL 100 patches the water vapor transmission rate was found to be higher at 75% RH, RT conditions. Therefore at both % RH, RT conditions the PVA and Eudragit RL 100 patches provide the best resistance to water vapor.
How to cite this article: V Sarkar, KC Yadav, Formulation and evaluation of prolonged release transdermal drug delivery system of atenolol for the treatment of hypertension, 2014, 2(2), 134-140
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Mishra AN and Jain NK. Transdermal Drug Delivery: Controlled and Novel Drug Delivery. 1st ed. (pp.100-101). CBS Publisher and Distributor, New Delhi, 1997.
2. Madison KC. Barrier function of the skin: “laraison d'etr” of the epidermis. J invest dermatol. 2003; 121(2): 231-241.
3. Aquil M. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil. Pharmazie. 2004; 59: 631-635.
4. Arabi H, Hashemi S, Ajdari N. Preparation of a transdermal delivery system and effect of membrane type for scopolamine drug. Iranian polymer J. 2002; 11(4): 245-249.
5. Mamatha T, Venkateswara RJ, Mukkanti K, Ramesh G. Transdermal drug delivery for Atomoxetine hydrochloride? in vitro and ex vivo evaluation. Current Trends in Biotech and Pharmacy. 2009; 3(2): 188?196.
6. Stucker M, Struk P, Altmeyer M, Herde H, Baumgartl, Lubbers DW. The coetaneous up take of atmospheric oxygen contributes significantly to the oxygen supply of human dermis and epidermis. J of physiology. 2002; 538(3): 985-994.
7. Munden BJ, Dekay HG, Banker GS. Evaluation of polymeric materials Screening of film coating agents. J Pharm Sci. 1964; 53(4): 395?401.
8. Budavari S. The Merck Index. 13th ed. Merck & Co. Inc. Whitehouse Station, NJ (2001) 147.
9. The Indian Pharmacopoeia. 4th ed. The Controller of Publications. Ministry of health and family welfare, Govt. of India. New Delhi (1996) 72.
10. Chandrashekar NS, Rani RHS. Design, Fabrication and calibration of modified franz diffusion cell for transdermal diffusion studies. Int J Pharm Excip. 2005; 3: 104-106.
11. Eliassaf J. Detection of small quantity of Poly (vinyl alcohol) in Poly (vinyl chloride) resins. Polymer Letters. 1972; 16: 225-235.
12. Gupta SP, Jain SK. Development of matrix membrane transdermal drug delivery system for atenolol. Drug Del. 2004; 11(5): 281-286.
13. Krishna R, Pandit JK. Transdermal delivery of Propranolol. Industrial Pharmacy. 1994; 20(15): 2459-2465.
14. Ramarao P, Ramakrishna S, Diwan PV. Drug release kinetics from polymeric films containing Propranolol hydrochloride for transdermal use. Pharm Dev and Tech. 2000; 5(4): 465?472.
15. Samanta MK, Dube R, Suresh B. Transdermal drug delivery system of Haloperidol to overcome self induced extrapyramidal syndrome. Drug Dev Indian Pharm. 2003; 29(4): 405?415.
16. Saini TR, Seth AK, Agrawal GP. Evaluation of free films. Indian drugs. 1985; 23(1): 45?47.
17. Raghuraman S, Velrajan R, Ravi B, Jeyabalan D, Benito J, Sankar V. Design and evaluation of Propranolol hydrochloride buccal films. Indian J Pharm Sci. 2002; 64(1): 32?36.
18. Devi VK, Saisivam S, Maria GR, Deepti PU. Design and evaluation of matrix diffusion controlled transdermal patches of Verapamil hydrochloride. Drug Dev Indian Pharm. 2003; 29(5): 495?503.
19. Murthy SN, Hiremath SSR. Preformulation studies of transdermal films of hydroxyl propylmethylcellulose and sodium carboxymethylcellulose. Int J Pharm Excip. 2002; 4: 34?38.
20. Crawford RR, Esmerian OK. Effect of plasticizers on some physical properties of cellulose acetate phthalate films. J Pharm Sci. 1971; 60: 312?314.
21. Keshary PR, Chien YW. Mechanism of transdermal nitroglycerin administration: development of finite dosing skin permeation system. Drug Dev Indian Pharm. 1984; 10(6): 883?913.
22. Kakkar AP, Gupta A. Gelatin based transdermal therapeutic system. Indian Drugs. 1992; 29(7): 308-311
23. Mutalik S, Udupa N. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of Glibenclamide. J Pharm Pharmaceut Sci. 2005; 8(1): 26?38.
24. Chandrashekar NS, Shobharani RH. Design, fabrication and calibration of modified diffusion cell for transdermal diffusion studies. Int J Pharm Excip. 2005; 3: 105.
25. Draize JH, Woodward G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944; 82: 377?390.
.png)
